Okay, some questions ...
For Genotypes 2,4,5,6 they are not recomending Sof/Dac. Is this due to inferiority or has BMS simply not persued approval? Are the recomendations the same in Europe?
For people in these genotypes who need generics, is there any reason to not choose the Sof/Dac combo?
Where are we standing now (or soon) on the availabilities of generic forms of the newer combos. (Sof/Vel/Vox, and AbbVie's combos, etc.)